RXi Pharmaceuticals Corporation (NASDAQ: RXII) announced today the departure of Dr. Alexey Eliseev, Chief Business Officer of the Company, effective ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE